Kliniska studier för KOL i Tennessee
14 studier för KOL söker deltagare vid platser i Tennessee.
Städer i Tennessee
Officiell studietext (engelska)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Chattanooga Research and Medicine- Site Number : 8400026, Chattanooga
- Premier Research Center, Llc- Site Number : 8400146, Hendersonville
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Meharry Medical College- Site Number : 8400133, Nashville
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07190209An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Fort Sanders Regional Medical Center (StatCare), Knoxville
Rekryterar
Ålder 40 till 80 · Alla kön · Uppdaterad 17 sep. 2026 · NCT06035120A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Chattanooga
- Research Site, Franklin
RekryterarFas 2
Ålder 40 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Vanderbilt University Medical Center, Nashville
RekryterarFas 2
Ålder 40 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Knoxville
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Franklin
- Research Site, Johnson City
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Clinical Trials Center of Middle Tennessee, LLC, Franklin
- Premier Research Center, LLC, Hendersonville
RekryterarFas 2/3
Ålder 35 till 80 · Alla kön · Uppdaterad 31 aug. 2026 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Chattanooga
- Research Site, Franklin
- Research Site, Tullahoma
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 26 aug. 2026 · NCT06283966Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators
- The University of Tennessee Graduate School of Medicine, Knoxville
RekryterarFas 4
Ålder 40 och äldre · Alla kön · Uppdaterad 17 aug. 2026 · NCT07133880eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Knoxville
RekryterarFas 3
Ålder 40 till 75 · Alla kön · Uppdaterad 28 juli 2026 · NCT07177339Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Methodist LeBonheur Healthcare, Memphis
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 10 juli 2026 · NCT05181826Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Knoxville
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 9 apr. 2026 · NCT06961214Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- The Jackson Clinic, PA, Jackson
RekryterarObservationsstudie
Ålder 50 och äldre · Alla kön · Uppdaterad 5 aug. 2025 · NCT06122077Från ClinicalTrials.gov, data hämtad 2 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.